Sun Pharmaceutical to invest additional Rs 200 crore in Assam plant
Sun Pharmaceutical Industries is going to invest an additional Rs 200 crore at its Assam plant to augment operations. The company has already invested Rs 700 crore in this manufacturing facility.
Besides, the company has inaugurated a new production line at its facility in Palashbari.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.